Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Research Report 2021 - Impact of COVID-19 on the Market

The Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.

Considering the influence of COVID-19 on the global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market are:
Pfizer CentreSource
Aenova Holding GmbH
Covance Inc.
Pharmaceutical Product Development LLC
Lonza Group
Boehringer Ingelheim Group
Syneos Health Inc.
Baxter Biopharma Solutions
CMIC Holdings Co. Ltd
Famar SA
Recipharm AB
LSK Global Pharma Service Co Ltd.
PAREXEL International Corporation
Jubilant Life Sciences Ltd.
Catalent Inc.
Patheon Inc.
Novotech Pty Ltd.

Most important types of Pharmaceutical Contract Development and Manufacturing Organization (CDMO) products covered in this report are:
Form/Fill Drug Product CDMO
Biologics Drug Substance CDMO

Most widely used downstream fields of Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market covered in this report are:
Preclinical
Phase I
Phase II
Phase III
Phase IV

Major Region

s or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.

Years considered for this report:

Historical Years:

2016-2020

Base Year:

2020

Estimated Year:

2021

Forecast Period:

2021-2026